ESP Block for Post-Surgery Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of a nerve block, called the Erector Spinae Plane (ESP) block, in reducing pain after spine surgery. Patients often experience significant pain following these surgeries, which can slow recovery and affect daily life. The trial tests whether an ESP block with a mix of local anesthetics (lidocaine and bupivacaine) manages pain better than a placebo (inactive treatment). It is open to adults undergoing certain types of spine surgeries, excluding those with conditions like spine fractures or tumors. As an unphased trial, this study offers patients the chance to contribute to research that could enhance pain management for future spine surgery patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the ESP Block is safe for postoperative pain management?
Research has shown that the Erector Spinae Plane (ESP) block is generally safe for managing post-surgical pain. Studies have found that ESP blocks effectively reduce pain and decrease the need for painkillers after spinal surgeries. They are widely used and well-tolerated in these situations.
Using a combination of lidocaine and bupivacaine (types of local anesthetics) in ESP blocks has effectively lowered pain levels and reduced the need for other pain medications. Reports suggest that patients experience fewer side effects and complications compared to some other pain management methods. This indicates that the treatment is considered safe and well-tolerated for patients undergoing surgery.
For those considering participation in a clinical trial involving an ESP block, these findings may provide reassurance about its safety based on previous studies.12345Why are researchers excited about this trial?
Researchers are excited about the Erector Spinae (ESP) Block for post-surgery pain management because it offers a novel approach by specifically targeting the nerves around the spine to block pain signals more effectively. This method uses a precise mixture of Lidocaine and Bupivacaine, which are well-known anesthetics, providing potentially longer-lasting and more localized pain relief compared to traditional systemic pain medications like opioids or NSAIDs. The ESP Block is administered at the T1 level, which is thought to offer a more focused pain management solution, reducing the need for higher doses of oral pain medications and minimizing their side effects.
What evidence suggests that the ESP Block is effective for post-surgery pain?
Research has shown that the erector spinae plane (ESP) block can help manage pain after spine surgery. In this trial, participants in the study group will receive the ESP block with Lidocaine and Bupivacaine. Studies have found this combination results in less pain and a reduced need for painkillers. Participants also experienced longer intervals before needing additional pain relief. Pain relief immediately after surgery and during early recovery was significantly better with the ESP block compared to a placebo. This suggests that the ESP block can play an important role in managing pain after spine surgery, aiding recovery with less discomfort.26789
Who Is on the Research Team?
Michael Dinsmore, MD
Principal Investigator
University Health Network, Toronto
Are You a Good Fit for This Trial?
Adults aged 18-80 with moderate health (ASA class I - III) who are having specific neck spine surgery for cervical stenosis can join. Not for those with certain spine conditions, very poor health (ASA IV), no consent, pregnancy, or allergy to local anesthetics.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a bilateral ESP block with a mixture of Lidocaine and Bupivacaine or a placebo saline solution at the T1 level
Follow-up
Participants are monitored for postoperative pain and opioid consumption using a visual analog scale and diary card
What Are the Treatments Tested in This Trial?
Interventions
- Erector Spinae (ESP) Block with Lidocaine/Bupivacaine
- Erector Spinae (ESP) Block with placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor